pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
PFIZER · news · pharmadog
← back to PFIZER
News mentioning PFIZER
392
stories
Oct 16, 26
Ambrose Healthcare inks $181M deal for former Pfizer target AM-Pharma
fiercebiotech
Oct 15, 26
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
biospace
Oct 14, 26
‘Pharma bro’ Shkreli runs afoul of court’s lifetime pharma ban
biospace
Oct 14, 26
J&J earnings set ‘negative tone’; Shkreli vs. the FTC
biopharma dive
Oct 14, 26
Verdiva ends mid-stage study of oral GLP-1 amid ‘market evolution’
biospace
Oct 13, 26
Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs
fiercebiotech
Oct 13, 26
BioNTech mRNA cancer immunotherapy misses first objective in key study
biopharma dive
Oct 13, 26
Beam suggests it can correct mutation; Pfizer to collaborate with Enodia
endpoints
Oct 13, 26
Pfizer pens $500M+ deal with Enodia to destroy disease-causing proteins
biospace
Oct 9, 26
FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts
biopharma dive
Oct 9, 26
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
biospace
Oct 9, 26
GSK drinks in Chai Discovery’s AI models after wet-lab validation
fiercebiotech
Oct 9, 26
Pfizer pens $500M Enodia pact to join Lilly in emerging protein degrader field
fiercebiotech
Oct 8, 26
Ono pays Biohaven $80M for protein degrader; UK pulls Valneva's chikungunya shot
endpoints
Oct 8, 26
Q3 layoffs down YOY, with 90% fewer biopharma employees affected
biospace
Oct 7, 26
Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
biospace
Oct 7, 26
5 biggest venture capital raises of Q3 2026
biospace
Oct 6, 26
STAT+: AstraZeneca opens new Boston site
stat
Oct 6, 26
STAT+: Are stem cell treatments about to have their day?
stat
Oct 6, 26
Compliance concerns hinder rollout of AI in drug manufacturing: Survey
biospace
Oct 6, 26
Kairos seizes moment to push prostate cancer prospect into earlier setting
fiercebiotech
Oct 6, 26
Opinion: Why the FDA should not approve an ineffective multicancer screening test
stat
Oct 5, 26
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
stat
Oct 5, 26
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
stat
Oct 5, 26
Vaxcyte skyrockets on ‘near best-case’ pneumococcal vaccine data
biopharma dive
Oct 5, 26
Vaxcyte rises as pneumococcal shot establishes ‘new competitive moat’ vs. Pfizer, Merck
biospace
Oct 5, 26
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
stat
Oct 5, 26
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
stat
Oct 5, 26
Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots
fiercebiotech
Oct 5, 26
Roivant, the 'inveterate drug hunters', enters commercial era with Lisraya
biospace
← prev
page 4 of 14
next →